These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients. Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, Kroese FGM. J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747 [Abstract] [Full Text] [Related]
3. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C. Arthritis Rheum; 2005 Jun; 52(6):1773-84. PubMed ID: 15934082 [Abstract] [Full Text] [Related]
4. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD. Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719 [Abstract] [Full Text] [Related]
6. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Carbone A, Gloghini A, Ferlito A. Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1170-5. PubMed ID: 11130833 [Abstract] [Full Text] [Related]
7. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice. Kurosawa M, Shikama Y, Furukawa M, Arakaki R, Ishimaru N, Matsushita K. Int J Mol Sci; 2021 Feb 25; 22(5):. PubMed ID: 33669065 [Abstract] [Full Text] [Related]
8. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome. Lee KE, Kang JH, Yim YR, Kim JE, Lee JW, Wen L, Park DJ, Kim TJ, Park YW, Yoon KC, Lee JS, Lee SS. Clin Exp Rheumatol; 2017 Feb 25; 35(2):234-240. PubMed ID: 27782867 [Abstract] [Full Text] [Related]
9. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome. Fava RA, Kennedy SM, Wood SG, Bolstad AI, Bienkowska J, Papandile A, Kelly JA, Mavragani CP, Gatumu M, Skarstein K, Browning JL. Arthritis Res Ther; 2011 Feb 25; 13(6):R182. PubMed ID: 22044682 [Abstract] [Full Text] [Related]
14. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Peck AB, Nguyen CQ, Ambrus J. Int J Mol Sci; 2021 Feb 15; 22(4):. PubMed ID: 33671965 [Abstract] [Full Text] [Related]
15. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Salomonsson S, Larsson P, Tengnér P, Mellquist E, Hjelmström P, Wahren-Herlenius M. Scand J Immunol; 2002 Apr 15; 55(4):336-42. PubMed ID: 11967114 [Abstract] [Full Text] [Related]
16. Repertoire Analysis of B-Cells Located in Striated Ducts of Salivary Glands of Patients With Sjögren's Syndrome. Visser A, Verstappen GM, van der Vegt B, Vissink A, Bende RJ, Bootsma H, Bos NA, Kroese FGM. Front Immunol; 2020 Apr 15; 11():1486. PubMed ID: 32760405 [Abstract] [Full Text] [Related]
17. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Hansen A, Lipsky PE, Dörner T. Arthritis Res Ther; 2007 Apr 15; 9(4):218. PubMed ID: 17697366 [Abstract] [Full Text] [Related]